Alcohol-Related Liver Disease May be More Deadly Among Women than Men, Study Suggests
Risk of mortality from ALD and MetALD was significantly higher among women even though both phenotypes were more prevalent among men, a new study reveals.
FDA Renews Warning Against Use of Tianeptine-Containing Products, aka “Gas Station Heroin”
Reported adverse events of products with tianeptine include seizures, loss of consciousness, and death, according to the FDA.
Investigational Nonopioid VX-548 Reduces Moderate to Severe Post-Surgical Pain in Late-Stage Clinical Trials
Oral VX-548 has the potential to fill the gap between drugs that are tolerable but lack efficacy and opioids with therapeutic efficacy but known risks, according to Vertex.
Daily Dose: Outpatient C. difficile Underdiagnosed in US
Your daily dose of the clinical news you may have missed.
As Measles Outbreak Persists, AAP Urges Clinicians to Ramp Up Infection Control Steps
Measles cases are reported in 6 states, which is not a surprise to one pediatrician who points to the ongoing consequences of falling vaccination rates.
Risk of Preeclampsia, Preterm Birth Prevented as Well by Low-dose Calcium as by Recommended High-Dose, Study Finds
Low-dose calcium supplementation with 500 mg/day may be as protective against poor pregnancy outcomes as the WHO-recommended dose of 1500 mg/day.
Dupilumab Safe for Patients with Moderate-to-Severe Asthma for up to 6 Years
New data suggest that dupilumab is safe for long-term use among patients with moderate-to-severe asthma or OCS-dependent severe asthma.
Daily Dose: Vaccination Reduces Risk of Long COVID in Children
Risk for Incident Asthma and Exacerbations Increases with Atopic Dermatitis in Dose-Dependent Fashion: Study
The risk of asthma and poor outcomes was even greater among children with both conditions than among adults in this first study to compare the 2 populations.
Opioid with 'Overdose Protection' Formulation Wins FDA Breakthrough Designation
The investigational combination opioid from Ensysce Biosciences is designed to deter abuse as well as prevent accidental or intentional overdose, the company said.
More than Half of US Adults Still Don't Recognize Heart Disease as #1 Cause of Death
Heart disease has been the primary cause of death in the US for the last century, and yet 51% of adults do not recognize the fact.
Comorbid Depression and IBD Significantly Increases Risk of Hospital Readmission, Mortality, According to National Database Review
Already high rates of readmission and mortality at 30 days rose significantly higher at 90 days, according to this National Readmissions Database review.
Daily Dose: Gabapentinoids & Risk of Severe COPD Exacerbations
New Study Highlights Primary Drivers of Cost of Inflammatory Bowel Disease Care
Unplanned emergency service and medication utilization make up the majority of costs of IBD care, reported researchers.
FDA Approves Dupilumab for Eosinophilic Esophagitis in Children Aged 1 to 11 Years
Dupilumab is the first agent approved to treat EoE in this vulnerable pediatric population.
The Most Effective Medications for Acute Migraines: Patient Perspectives
Which medications are most effective for acute migraine management? A recent study assessed which ones appeared to work best based on reported patient experience.
Individuals with IBD Hospitalized for COVID-19 at High Risk for Shock, Organ Injury Suggests National Analysis
Among more than 1.5 million persons hospitalized for COVID-19, a history of Crohn disease or ulcerative colitis significantly increased risk for poor outcomes.
Daily Dose: Bempedoic Acid Linked to 20% Reduction in Total CV Events
Survey Data Highlight Need for Education on Ulcerative Colitis Among Primary Care Clinicians
Survey findings presented at the Crohn’s & Colitis Congress suggest a need for education among some health care specialists about the clinical presentation of ulcerative colitis.
Vagus Nerve Stimulation Shows Promise Against Daytime Sleepiness in Narcolepsy: Novel Study
The effect of vagus nerve stimulation persons with narcolepsy revealed a specific, notable improvement in daytime sleepiness in a novel open-label study.
